SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SolarEdge Technologies, Inc. – SEDG
NEW YORK, Nov. 28, 2023 /PRNewswire/ –Pomerantz LLP is investigating claims on behalf of investors of SolarEdge Technologies, Inc. (“SolarEdge” or the “Company”) (NASDAQ: SEDG). Such investors are advised to contact Robert S. Willoughby at [email protected] or 88
SeatCash Inc. Announces the Beta Launch of FareX.ai: The Next Generation Airfare Prediction Tool
CHICAGO, Nov. 28, 2023 /PRNewswire/ — SeatCash Inc., a leader in travel technology innovation is excited to announce the launch of FareX.ai, its proprietary airfare prediction tool. FareX.ai is designed to empower both businesses managing air travel procurement and individual travelers by prov
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Rockley Photonics Holdings Limited – RKLY; RKLY.W
NEW YORK, Nov. 28, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Rockley Photonics Holdings Limited (“Rockley” or the “Company”) (NASDAQ: RKLY; RKLY.W). Such investors are advised to contact Robert S. Willoughby at newaction@poml
LA PLAZA FOCUSES ON L.A.’s SHARED RACIAL HISTORY THROUGH FOOD, A DISCUSSION ON LATINOS IN HOLLYWOOD, AND AN ECLECTIC FAMILY DAY FILLED WITH MUSIC, ART AND MORE
LA Plaza de Cultura y Artes presents a series of events focusing on race in a program organized by the Smithsonian, in collaboration with the Chinese American Museum and the Japanese American National Museum, December 1 through 17, 2023 LOS ANGELES, Nov. 28, 2023 /PRNewswire/ — LA Plaza de Cul
SENIOR ACADEMIC PHILANTHROPY LEADER KIM M. MORTON, JD, MA, NAMED NEW ASSOCIATE DEAN FOR DEVELOPMENT AT UNIVERSITY OF MARYLAND MEDICINE
New Associate Dean Brings Strong Track Record of Success to Newly-Aligned UMSOM and UMMC Advancement Unit BALTIMORE, Nov. 28, 2023 /PRNewswire/ — University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, along with University of Maryland Medical Center (UMMC) President an
LexisNexis Risk Solutions Receives Two Awards for its Innovation in Payments Risk Management and Fraud and Identity Solutions
Recognitions Showcase LexisNexis ThreatMetrix Capabilities That Help Clients Navigate Cybersecurity Risks in Asia-Pacific SYDNEY, Nov. 29, 2023 /PRNewswire/ — LexisNexis® Risk Solutions has received industry awards from two prominent awarding bodies in Asia-Pacific (APAC) in recognition of it
Kailo Medical Presents: KailoFlow – Elevating the Generative Reporting Experience to the Web
CHICAGO, Nov. 28, 2023 /PRNewswire/ – Kailo Medical, a recognized leader in medical software and services, proudly announces the launch of KailoFlow, the web-based evolution of the premier structured reporting platform, SonoReview. Marrying progress, innovation, and accessibility, KailoFlow is
Humanforce Announces Strategic Partnership with Pinpoint HRM: Delivering Exceptional Customer Experiences for Frontline Workforces
SYDNEY, Nov. 29, 2023 /PRNewswire/ — Humanforce, an Australian-borne global provider of human capital management (HCM) solutions, today announced a new strategic partnership with Pinpoint HRM, leading HR technology project experts in the A/NZ region. This strategic partnership brings together
Navigating the Evolving Market Dynamics of Bone Sarcoma: A Comprehensive Analysis of Osteosarcoma, Ewing Sarcoma, and Chondrosarcoma | DelveInsight
Each individual’s risk of being diagnosed with primary bone sarcoma and their chances of recovery following diagnosis are influenced by a range of unique factors. In 2023, it is anticipated that 4K individuals of all ages in the United States will be diagnosed with primary bone sarcoma, includ
ALIMENTATION COUCHE-TARD ANNOUNCES ITS RESULTS FOR ITS SECOND QUARTER OF FISCAL YEAR 2024
Net earnings were $819.2 million, or $0.85 per diluted share for the second quarter of fiscal 2024 compared with $810.4 million, or $0.79 per diluted share for the second quarter of fiscal 2023. Adjusted net earnings1 were approximately $792.0 million compared with $838.0 million for the second quar
